Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia

BACKGROUND: This post hoc analysis of clinical trial data evaluated long-term, self-reported mental and physical health-related quality of life (HRQoL) scores in schizophrenia patients receiving aripiprazole lauroxil (AL), an atypical long-acting injectable (LAI) antipsychotic approved for the treat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Psychiatry
Egile Nagusiak: McEvoy, Joseph P., Weiden, Peter J., Lysaker, Paul H., Sun, Xiaowu, O’Sullivan, Amy K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7992347/
https://ncbi.nlm.nih.gov/pubmed/33761928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-021-03124-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak